Exoiq GMBH
USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2022–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B25J (MANIPULATORS; Chambers Provided With Manipulation Devices).
The verdict
According to USPTO PatentsView, Exoiq ranks #46,630 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.
- #46,630
- of 49,997 US assignees by volume
- Top 24%
- by Innovation Score (45.0/100)
- 21.2
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R46630 · Foreign Corporation #46,630 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #46,630/49,997
- PHOTO-FINISH Exela Sterile…
- CPC-NARROW B25J · 3 areas
- INNOV-PAR 45.0/100
- CLAIMS-DENSE 21.2 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2022–2024 · 3y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Exela Sterile Medicines LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Exoiq’s 45.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Exoiq
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Exoiq · this assignee
Exoiq · this assignee
45 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Exoiq's Innovation Score is 45.0/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Exoiq?
Each dot is one of Exoiq’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Exoiq’s own 21.2 claims/patent is ABOVE the 10.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Exoiq's grants concentrate
Exoiq GMBH is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under B25J (MANIPULATORS; Chambers Provided With Manipulation Devices). Peak complete grant year is 2022 (3 grants) versus a trough of 2 in 2024. By volume, Exoiq sits between Exela Sterile Medicines LLC and Exotex, Inc..
Exoiq's three-year grant acceleration
Exoiq GMBH shows 5 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Exoiq's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Exela Sterile Med…
Exela Sterile Medicines LLC
5 patents
- Exelway
Exelway Inc.
5 patents
- Exhalation Techno…
Exhalation Technology Limited
5 patents
- Exhaustless
Exhaustless, Inc.
5 patents
- Exonhit Therapeut…
Exonhit Therapeutics, SA
5 patents
- Exostemtech
Exostemtech Co., Ltd.
5 patents
- Exotec Solutions
Exotec Solutions
5 patents
- Exotex
Exotex, Inc.
5 patents
- Exoiq ◀
Exoiq GMBH
5 patents
What this shows Exoiq holds 5 patents at rank #46,490, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Exoiq
By rank, the assignees closest to #46,490 in granted patent volume.
- Exela Sterile Medicines LLC #46,486 · 5 patents
- Exelway Inc. #46,487 · 5 patents
- Exhalation Technology Limited #46,488 · 5 patents
- Exhaustless, Inc. #46,489 · 5 patents
- Exonhit Therapeutics, SA #46,491 · 5 patents
- Exostemtech Co., Ltd. #46,492 · 5 patents
- Exotec Solutions #46,493 · 5 patents
- Exotex, Inc. #46,494 · 5 patents
Leaders in B25J (Manipulators)
Other assignees with the most granted patents in Exoiq's primary technology class.
- Fanuc Corporation 999 in class
- Seiko Epson Corporation 608 in class
- Intuitive Surgical Operations, Inc. 470 in class
- X Development LLC 351 in class
- Kawasaki Jukogyo Kabushiki Kaisha 328 in class
- Kabushiki Kaisha Yaskawa Denki 215 in class
- ABB Schweiz AG 214 in class
- Ubtech Robotics Corp Ltd 197 in class
Exoiq's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
45 Top 24% higher than 76% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 3 | 60.0% |
| 2024 | 2 | 40.0% |
Which technologies does Exoiq GMBH patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Exoiq GMBH's patent record in context - here's where to go next.
- Exoiq GMBH's lead technology class is B25J (MANIPULATORS; Chambers Provided With Manipulation Devices), 100% of its portfolio - see every assignee active in that class. Explore B25J
- Ranked #46,630 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Exoiq GMBH against Exela Sterile Medicines LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 45.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.